Actively Recruiting

Phase 4
Age: 18Years - 75Years
All Genders
NCT05929755

Depo-Medrol on Psoas After LLIF

Led by Hardeep Singh · Updated on 2025-07-24

80

Participants Needed

1

Research Sites

207 weeks

Total Duration

On this page

Sponsors

H

Hardeep Singh

Lead Sponsor

S

Society for Minimally Invasive Spine Surgery

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.

CONDITIONS

Official Title

Depo-Medrol on Psoas After LLIF

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients from the practices of Drs. Singh, Mallozzi, Moss
  • Undergoing transpsoas lateral lumbar interbody fusion (LLIF) surgery at 1 to 3 disc levels including L3-4 and/or L4-5 with posterior instrumentation, with or without laminectomy
  • Agree to participate in the study
  • Diagnosed with lumbar disc degeneration
  • Aged between 18 and 75 years
Not Eligible

You will not qualify if you...

  • Scoliosis greater than 10 degrees
  • Spondylolisthesis greater than Grade 1
  • Flatback deformity
  • Insulin dependent diabetes
  • Fusion involving more than 3 levels
  • Use of alternative interbody devices
  • Chronic use of oral steroids
  • Allergy or intolerance to Depo-Medrol or other steroids
  • Bilateral transpsoas surgical approaches required
  • Ipsilateral symptomatic hip problems
  • Revision fusion surgeries
  • Surgery due to trauma, tumor, or infection
  • Unable to provide consent personally
  • Non-fluent in English
  • Lost to follow-up before two years after surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UConn Health

Farmington, Connecticut, United States, 06030

Actively Recruiting

Loading map...

Research Team

H

Hardeep Singh, MD

CONTACT

S

Study Coordinator

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here